Endophthalmitis associated with microbial keratitis

Ophthalmology. 1996 Nov;103(11):1864-70. doi: 10.1016/s0161-6420(96)30415-6.

Abstract

Purpose: The purpose of the study is to investigate possible risk factors, organisms cultured, and visual acuity outcomes of endophthalmitis associated with microbial keratitis.

Methods: Records were reviewed of all patients with both positive corneal and positive intraocular cultures at the Bascom Palmer Eye Institute between January 1, 1990, and March 31, 1995.

Results: Thirteen (92.9%) of 14 patients identified had documented keratitis before the diagnosis of endophthalmitis was made. Thirteen (92.9%) patients recently had used 1% prednisolone acetate eye drops, 2 (14.3%) received oral prednisone, and 5 (35.7%) were being treated for systemic conditions associated with relative immune dysfunction. Eight (57.1%) patients had a history of ocular surgery, and seven (50.0%) had wound abnormalities. Eight (57.1%) patients lacked an intact posterior capsule, four (28.6%) had a corneal perforation, and three (21.4%) had a history of dry eye. Gram-negative organisms (7), Staphylococcus aureus (3), streptococcal species (2), and fungi (4) were the most frequently isolated organisms. Coagulase-negative staphylococci were not isolated. Six (42.9%) patients achieved a post-treatment visual acuity of 20/200 or better. Three (21.4%) patients underwent enucleation or evisceration. Although not statistically significant, there was an association between appropriate initial antibiotic therapy and improved visual outcomes.

Conclusion: Patients in whom endophthalmitis associated with microbial keratitis develops have a frequent history of corticosteroid use, systemic conditions associated with relative immune dysfunction, lack of an intact posterior capsule, dry eye, wound abnormalities, and/or corneal perforation. In general, agents cultured consisted of organisms less frequently reported to be the causative agents in series of postoperative and post-traumatic endophthalmitis. Post-treatment visual outcomes generally were poor.

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use
  • Bacteria / isolation & purification
  • Corneal Ulcer / drug therapy
  • Corneal Ulcer / microbiology*
  • Corneal Ulcer / physiopathology
  • Endophthalmitis / drug therapy
  • Endophthalmitis / microbiology*
  • Endophthalmitis / physiopathology
  • Eye Infections, Bacterial / drug therapy
  • Eye Infections, Bacterial / etiology*
  • Eye Infections, Bacterial / physiopathology
  • Eye Infections, Fungal / drug therapy
  • Eye Infections, Fungal / etiology*
  • Eye Infections, Fungal / physiopathology
  • Female
  • Fungi / isolation & purification
  • Humans
  • Male
  • Microbial Sensitivity Tests
  • Middle Aged
  • Ophthalmic Solutions
  • Prednisolone / analogs & derivatives
  • Prednisolone / therapeutic use
  • Prednisone / therapeutic use
  • Prognosis
  • Retrospective Studies
  • Risk Factors
  • Visual Acuity

Substances

  • Anti-Inflammatory Agents
  • Ophthalmic Solutions
  • prednisolone acetate
  • Prednisolone
  • Prednisone